Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

Evidence from large-scale, randomized trials has shown that each reduction of 40 mg per deciliter (1 mmol per liter) in the level of low-density lipoprotein (LDL) cholesterol reduces the risk of coronary events (including coronary death, myocardial infarction, and revascularization procedures) and…

http://ift.tt/2iDNvwF